• ONX-0914: Assay Logic for Immune Proteasomes

  2026-08-21

  ONX-0914 (PR-957) is a selective LMP7 inhibitor for resolving how immunoproteasome activity shapes cytokine signaling. This guide connects autoimmune disease assays with a landmark antiviral study to improve experimental design, controls, and interpretation.

• N-MYC–eIF4G1 Axis in inv(16) AML

  2026-08-20

  Peramangalam et al. identify an N-MYC–eIF4G1 survival pathway that sustains inv(16) acute myeloid leukemia, linking a previously unrecognized MYCN enhancer to leukemic maintenance. The study combines transcriptomic analysis, enhancer investigation, functional perturbation, primary AML models, and patient-derived xenografts to support this axis as a mechanistic and therapeutic research framework.

• Annexin V-Cy5 Apoptosis Kit for Microglia

  2026-08-20

  Use the Annexin V-Cy5 Apoptosis Kit to separate true apoptotic-cell loss from lysosomal dysfunction in microglia models. Its 10-minute, one-step workflow supports both quantitative flow cytometry apoptosis detection and spatial fluorescence microscopy apoptosis analysis.

• ACE Inhibitor Pharmacology: Insights from Piepho

  2026-08-19

  Piepho’s review provides a comparative framework for understanding how ACE inhibitor structure, prodrug activation, tissue distribution, elimination, and exposure profiles influence clinical use. Its analysis is especially useful for interpreting Fosinopril sodium in hypertension research because it connects phosphinyl zinc binding and lipophilicity with pharmacokinetic and safety considerations.

• FCCP: Mitochondrial Uncoupling for HIF Studies

  2026-08-19

  FCCP, or carbonyl cyanide p-trifluoromethoxyphenylhydrazone, is a lipophilic mitochondrial uncoupler that dissipates the inner-membrane proton gradient. Its research value is strongest in controlled mitochondrial biology, metabolic regulation, and inhibition of hypoxia-inducible factor (HIF) pathway studies, where dose, cell type, and assay context determine interpretation.

• Diethylmaleate for GSH Depletion Workflows

  2026-08-18

  Diethylmaleate provides a practical way to perturb intracellular glutathione and connect redox changes with GST activity, ROS, apoptosis, and toxicant sensitivity. This guide translates insecticide-resistance findings into controlled workflows for oxidative stress, toxicology, and redox regulation studies.

• CHI3L1-IN-5: A Cell-State Assay Strategy

  2026-08-18

  CHI3L1-IN-5, also known as Compound Z17, offers a way to connect CHI3L1 inhibition with inflammatory signaling and astrocyte function. This guide develops an orthogonal assay strategy that separates target engagement, NF-κB suppression, and cellular repair in neurodegeneration research.

• HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody

  2026-08-17

  Turn human IgG measurements into clear, spatially resolved fluorescence data across immunofluorescence, Western blotting, flow cytometry, IHC, and ELISA. This guide pairs the HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody with practical assay design, vaccine-research context, and troubleshooting controls.

• Angiotensin II: From GPCR Signal to Translation

  2026-08-17

  A mechanistic and strategic guide to using Angiotensin II in vascular signaling, remodeling, hypertension, aneurysm, and emerging cross-domain research.

• AICAR and AMPK: A Mitophagy Assay Playbook

  2026-08-16

  AICAR provides a controlled pharmacological tool for testing AMPK-dependent energy metabolism regulation and mitochondrial quality control. This guide translates findings from a 2025 sarcopenic-obesity study into practical assay design, controls, and interpretation strategies.

• Angiotensin II (A1042): Practical Research Guide

  2026-08-15

  Angiotensin II (SKU A1042) provides a defined octapeptide stimulus for receptor-binding, vascular signaling, oxidative-stress, and remodeling experiments. This guide explains preparation, cell and animal workflow parameters, and quality controls, while clarifying that the product is for research use and that dossier benchmarks should not be treated as universal efficacy claims.

• ABT-199 Workflow for BCL-2 Apoptosis Research

  2026-08-15

  ABT-199 (Venetoclax) enables selective interrogation of BCL-2 dependence in hematologic models, with practical value for apoptosis assays, non-Hodgkin lymphoma research, and AML studies. This guide translates mechanistic evidence into a reproducible workflow while addressing solvent handling, assay timing, model selection, and interpretation limits.

• Fosinopril sodium for ACE Research

  2026-08-14

  Fosinopril sodium gives researchers a mechanistically distinctive ACE inhibitor for connecting zinc-site inhibition with blood pressure, cardiac, and renal readouts. Its prodrug activation, phosphinic acid binding group, and renal-hepatic elimination profile support carefully staged workflows rather than one-size-fits-all dosing.

• Hypertension, DNA Damage, and Atrial Fibrillation

  2026-08-13

  The reference study identifies excessive DNA damage response, particularly ATM/CHK2/p53 signaling, as a mechanistic link between persistent hypertension, atrial remodeling, and atrial fibrillation susceptibility. Its combination of human samples, spontaneously hypertensive rats, Angiotensin II-treated HL-1 cells, and ATM inhibition provides a useful framework for testing how hypertension-associated stress alters atrial electrical and structural phenotypes.

• Reactive Oxygen Species Assay Kit: Reliable ROS Data

  2026-08-13

  Learn how Reactive Oxygen Species Assay Kit K2065 supports quantitative ROS detection in live cells when viability results are inconsistent or mechanistic interpretation is unclear. This scenario-based guide covers probe chemistry, controls, optimization, data normalization, and practical vendor selection.

449 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page